But overall, our findings suggest cannabinoids may acutely influence sleep, primarily by suppressing REM sleep, without ...

Researchers from the Universidade do Porto have identified promising anti-cancer properties in four lesser-known cannabinoids ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

Artelo reports favorable Phase 1 results for its FABP5 inhibitor, showing strong safety data and dose-dependent absorption in ...

By targeting FABP5, ART26.12 modulates endogenous lipid signaling molecules that exert analgesic effects through established pathways, including TRPV1, PPAR alpha, and cannabinoid receptors, with ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

Additional support to our observation can be found in two independent binding/unbinding studies of ligands from cannabinoid receptors, which have discovered similar pathway using different CVs (Saleh, ...

According to a study published in Nature, researchers have uncovered a previously concealed binding site on the type 1 cannabinoid receptor (CB₁)—a pivotal component of the endocannabinoid system that ...

But other receptors and brain pathways may also be involved. Is CBD Safe for Treating Anxiety and Depression? Right now, CBD is only approved to treat certain seizure disorders.

Credit: Laura López. UPV/EHU. After testing the effect of the drug WIN55.212-2, which interacts with cannabinoid receptors, on rodents in the early stages of the disease, the team found “that they ...